Court approves Bayer’s Roundup class settlement

Key highlights
  • The Missouri court’s final approval order is subject to appeal.
  • Monsanto will make declining, capped annual payments for up to 21 years, totalling up to $7.25 billion, including payments already made.
  • The settlement covers people exposed before February 17, 2026, who have NHL or receive a diagnosis within 16 years of the agreement’s effective date.
  • An appeal would pause further Monsanto payments until the appeals are resolved.

Settlement approval

A Missouri state court granted final approval to a nationwide class settlement covering current and future claims alleging non-Hodgkin’s lymphoma (NHL) injuries from Roundup™. The approval order is subject to appeal. The agreement contains no admission of liability or wrongdoing.

Funding and eligibility

Monsanto will fund the settlement through declining, capped annual payments for up to 21 years, totalling up to $7.25 billion, inclusive of payments already made. The settlement covers people who allege exposure to Roundup™ before February 17, 2026, and have an NHL diagnosis or receive one within 16 years after the agreement’s effective date.

Appeals and remaining claims

An appeal of the approval order would pause further Monsanto payments until the appeals are exhausted. Bayer expects opt-outs to represent a very low percentage of current and potential future claims and says it is adequately provisioned for the remaining litigation.

Source: Bayer

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time. See our Privacy Policy.

Related articles

30 October 2026
Monsanto wins unanimous defense verdict in first post‑Durnell Roundup trial

Jury cleared Monsanto on design‑defect, fraud and negligence claims in a three‑plaintiff case — the first Roundup trial after the Supreme Court’s June 2026 Durnell ruling.

31 July 2025
Bayer Adjusts 2025 Sales Forecast and Increases US Litigation Provisions

Raises 2025 sales and earnings guidance; expects currency impacts; reports Q2 sales of €10.7B; sets €1.2B for Roundup litigation; settles 131,000 claims; awaits court rulings.

30 July 2025
Bayer Seeks Herbicide Approval in Four Key Markets

Icafolin-methyl, a new herbicide, targets weed resistance with unique properties. Launch expected in Brazil by 2028, with further expansion planned.